← The Wire
RCUSNYSE
Arcus Biosciences, Inc.
Pharmaceutical Preparations · DE · CIK 1724521
Arcus Biosciences, Inc. develops and commercializes novel immunotherapies for cancer
$2.99B
Market cap
$31.08
Last close
+0.3%
1D
+14.1%
5D
1.6M
Volume
Price · last 39 sessions+19.3%
May 4L $22.12 · H $31.08Jun 29
174
Total filings
Jun 12, 2026
Last filing
12/31
Fiscal year end
8-KShareholder VoteJun 12, 202610-Q10-QMay 5, 20268-KResults of OperationsMay 5, 2026DEFA14ADEFA14AApr 21, 2026DEF 14ADEF 14AApr 21, 20268-KCompany UpdateApr 20, 20268-KExecutive ChangeMar 23, 202610-K10-KFeb 25, 20268-KResults of OperationsFeb 25, 20268-KMaterial Agreement · New Debt / ObligationDec 18, 20258-KCompany UpdateDec 12, 20258-KCompany UpdateNov 3, 2025424B5424B5Oct 31, 2025424B5424B5Oct 30, 202510-Q10-QOct 28, 20258-KResults of OperationsOct 28, 20258-KCompany UpdateOct 14, 20258-KCompany UpdateOct 6, 202510-Q10-QAug 6, 20258-KResults of OperationsAug 6, 20258-KShareholder Vote · Company UpdateJun 12, 20258-KReg FD Disclosure · Company UpdateJun 2, 202510-Q10-QMay 6, 20258-KResults of OperationsMay 6, 2025DEFA14ADEFA14AApr 22, 2025DEF 14ADEF 14AApr 22, 202510-K10-KFeb 25, 20258-KResults of OperationsFeb 25, 20258-KCompany UpdateFeb 19, 2025424B5424B5Feb 18, 20258-KResults of Operations · Company UpdateFeb 18, 20258-KExecutive ChangeFeb 6, 20258-KExecutive ChangeJan 21, 202510-Q10-QNov 6, 20248-KResults of OperationsNov 6, 20248-KReg FD Disclosure · Company UpdateOct 24, 20248-KMaterial Agreement · New Debt / ObligationAug 27, 202410-Q10-QAug 8, 20248-KResults of OperationsAug 8, 20248-KShareholder Vote · Company UpdateJun 6, 20248-KReg FD Disclosure · Company UpdateJun 3, 20248-KCompany UpdateMay 23, 202410-Q10-QMay 8, 20248-KResults of OperationsMay 8, 2024DEFA14ADEFA14AApr 23, 2024DEF 14ADEF 14AApr 23, 202410-K10-KFeb 21, 20248-KResults of OperationsFeb 21, 2024SC 13GSC 13GFeb 9, 20248-KExecutive Change · Material AgreementJan 30, 2024SC 13GSC 13GJan 24, 202410-Q10-QNov 7, 20238-KResults of OperationsNov 7, 202310-Q10-QAug 7, 20238-KResults of OperationsAug 7, 20238-KMaterial Agreement · Equity IssuanceJun 28, 20238-KShareholder Vote · Company UpdateJun 16, 20238-KReg FD Disclosure · Company UpdateJun 5, 20238-KMaterial AgreementMay 15, 202310-Q10-QMay 9, 20238-KResults of OperationsMay 9, 2023DEFA14ADEFA14AApr 21, 2023DEF 14ADEF 14AApr 21, 20238-KExecutive ChangeMar 10, 202310-K10-KFeb 28, 20238-KResults of OperationsFeb 28, 2023SC 13GSCHEDULE 13GFeb 9, 20238-KCompany UpdateDec 19, 20228-KCompany UpdateNov 28, 202210-Q10-QNov 2, 20228-KResults of OperationsNov 2, 2022SC 13GSC 13GOct 17, 20228-KMaterial AgreementOct 11, 202210-Q10-QAug 3, 20228-KResults of OperationsAug 3, 20228-KShareholder Vote · Company UpdateJun 16, 202210-Q10-QMay 9, 20228-KResults of OperationsMay 9, 2022SC 13GSC 13GMay 9, 2022DEFA14ADEFA14AApr 20, 2022
Insider Activity
In the 90 days to Jan 5, 2026: 7 sold $10.9M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 5, 2026 | Jaen Juan C.President | Sell | 29,670 | $21.34 | $633K |
| Jan 5, 2026 | Jaen Juan C.President | Sell | 2,053 | $22.34 | $46K |
| Jan 5, 2026 | Jaen Juan C.President | Sell | 100 | $23.20 | $2K |
| Dec 31, 2025 | Goeltz Ii Robert C.Chief Financial Officer | Sell | 6,552 | $23.38 | $153K |
| Dec 18, 2025 | Azoy AlexanderChief Accounting Officer | Sell | 4,343 | $22.25 | $97K |
| Dec 17, 2025 | Rosen Terry JChief Executive Officer | Sell | 25,744 | $22.16 | $570K |
| Dec 17, 2025 | Jarrett JenniferChief Operating Officer | Sell | 9,983 | $22.16 | $221K |
| Dec 17, 2025 | Jaen Juan C.President | Sell | 9,983 | $22.16 | $221K |
| Dec 17, 2025 | Tang Carolyn C.General Counsel | Sell | 6,810 | $22.16 | $151K |
| Dec 17, 2025 | Goeltz Ii Robert C.Chief Financial Officer | Sell | 5,960 | $22.16 | $132K |
| Dec 17, 2025 | Markus RichardChief Medical Officer | Sell | 4,494 | $22.16 | $100K |
| Dec 17, 2025 | Azoy AlexanderChief Accounting Officer | Sell | 2,113 | $22.16 | $47K |
| Dec 16, 2025 | Rosen Terry JChief Executive Officer | Sell | 28,947 | $21.88 | $633K |
| Dec 16, 2025 | Jarrett JenniferChief Operating Officer | Sell | 11,225 | $21.88 | $246K |
| Dec 16, 2025 | Jaen Juan C.President | Sell | 11,225 | $21.88 | $246K |
| Dec 16, 2025 | Tang Carolyn C.General Counsel | Sell | 7,658 | $21.88 | $168K |
| Dec 16, 2025 | Goeltz Ii Robert C.Chief Financial Officer | Sell | 6,702 | $21.88 | $147K |
| Dec 16, 2025 | Markus RichardChief Medical Officer | Sell | 5,052 | $21.88 | $111K |
| Dec 16, 2025 | Azoy AlexanderChief Accounting Officer | Sell | 2,376 | $21.88 | $52K |
| Dec 4, 2025 | Jaen Juan C.President | Sell | 82,997 | $24.71 | $2.1M |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance